Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Circulation. 1957;15:502-511

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KATTUS, A. A.
Right arrow Articles by Yamashita, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KATTUS, A. A.
Right arrow Articles by Yamashita, J.

(Circulation. 1957;15:502.)
© 1957 American Heart Association, Inc.

Diagnostic and Prognostic Significance of Serum Transaminase Levels in Coronary Occlusive Disease

A. A. KATTUS M.D.1; R. WATANABE M.D.1; C. SEMENSON M.D.1; Joe Yamashita 1

1 From Wadsworth Veterans Administration Hospital and the UCLA Medical Center, Los Angeles, Calif.

Clinical and experimental studies of acute myocardial infarction suggest that serum glutamic oxalacetic transaminase (SGO-T) levels may have both diagnostic and prognostic significance. The authors report their experience in 255 patients hospitalized because of chest pain strongly suggestive of acute myocardial infarction. The results of serial determinations are compared with the clinical data and the electrocardiographic findings. The data indicate that abnormally high levels have both diagnostic and prognostic significance.






Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 1957 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.